5 withdrawn. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Withdrawn 5 |
| Phase 1 | 1 | Withdrawn 1 |
Follow plerixafor: new trials by email Literature Review of plerixafor trials Research Report on plerixafor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peripheral Blood Stem Cell Collection From Patients With Sickle Cell Disease (SCD) Using Plerixafor Plerixafor - Sickle Cell Disease | Phase 2 | Withdrawn | St. Jude Children's Research Hospital | 2023-04-01 | 2023-04-07 | |
| Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb) Plerixafor 20 MG/ML [Mozobil], Placebo - COVID-19 Acute Respiratory Distress Syndrome, COVID-19 | Phase 2 | Withdrawn | 4Living Biotech | 2022-07-19 | 2023-04-10 | |
| AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma AMD3100, Pembrolizumab - Head and Neck Cancer | Phase 2 | Withdrawn | Massachusetts General Hospital | 2019-09-30 | 2020-09-07 | |
| Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers Neupogen, Hyperbaric oxygen therapy, Plerixafor - Bone Marrow Transplantation, Hematopoietic Stem Cells | Phase 2 | Withdrawn | University of Maryland, Baltimore | 2015-10-01 | 2019-12-11 | |
| AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS AMD3100, Allogeneic Stem Cell Transplantation - Acute Myelogenous Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | Withdrawn | Genzyme, a Sanofi Company | 2014-02-11 |
Anemia, Sickle Cell (1) · COVID-19 (1) · Head and Neck Neoplasms (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1)
4Living Biotech (1) · Genzyme, a Sanofi Company (1) · Massachusetts General Hospital (1) · St. Jude Children's Research Hospital (1) · University of Maryland, Baltimore (1)
United States (2) · Bulgaria (1) · France (1)
Akshay Sharma, MBBS (1) · Jong Chul Park, MD (1) · Mitch Weiss, MD, PhD (1)